These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 16551737

  • 1. Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model.
    Shi Y, Zou M, Collison K, Baitei EY, Al-Makhalafi Z, Farid NR, Al-Mohanna FA.
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2373-9. PubMed ID: 16551737
    [Abstract] [Full Text] [Related]

  • 2. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
    Jia W, Gao XJ, Zhang ZD, Yang ZX, Zhang G.
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
    [Abstract] [Full Text] [Related]

  • 3. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo.
    Zhang K, Yu M, Hao F, Dong A, Chen D.
    Cancer Biomark; 2016 Sep 26; 17(3):281-291. PubMed ID: 27802204
    [Abstract] [Full Text] [Related]

  • 4. Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma.
    Zou M, Famulski KS, Parhar RS, Baitei E, Al-Mohanna FA, Farid NR, Shi Y.
    J Clin Endocrinol Metab; 2004 Dec 26; 89(12):6146-54. PubMed ID: 15579771
    [Abstract] [Full Text] [Related]

  • 5. RNA interference targeting inhibition of S100A4 suppresses cell growth and promotes apoptosis in human laryngeal carcinoma Hep‑2 cells.
    Liu J, Fu S, Xu Y, Zheng Z.
    Mol Med Rep; 2014 Sep 26; 10(3):1389-94. PubMed ID: 24969174
    [Abstract] [Full Text] [Related]

  • 6. Short hairpin RNA-mediated inhibition of S100A4 promotes apoptosis and suppresses proliferation of BGC823 gastric cancer cells in vitro and in vivo.
    Hua J, Chen D, Fu H, Zhang R, Shen W, Liu S, Sun K, Sun X.
    Cancer Lett; 2010 Jun 01; 292(1):41-7. PubMed ID: 19945782
    [Abstract] [Full Text] [Related]

  • 7. Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma.
    Shi Y, Zou M, Baitei EY, Alzahrani AS, Parhar RS, Al-Makhalafi Z, Al-Mohanna FA.
    Cancer Gene Ther; 2008 Feb 01; 15(2):101-7. PubMed ID: 18197164
    [Abstract] [Full Text] [Related]

  • 8. Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma.
    Kim JE, Ahn BC, Hwang MH, Jeon YH, Jeong SY, Lee SW, Lee J.
    J Nucl Med; 2011 Nov 01; 52(11):1756-63. PubMed ID: 21994409
    [Abstract] [Full Text] [Related]

  • 9. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma.
    Zou M, Al-Baradie RS, Al-Hindi H, Farid NR, Shi Y.
    Br J Cancer; 2005 Nov 28; 93(11):1277-84. PubMed ID: 16265347
    [Abstract] [Full Text] [Related]

  • 10. Relaxin enhances S100A4 and promotes growth of human thyroid carcinoma cell xenografts.
    Radestock Y, Willing C, Kehlen A, Hoang-Vu C, Hombach-Klonisch S.
    Mol Cancer Res; 2010 Apr 28; 8(4):494-506. PubMed ID: 20332215
    [Abstract] [Full Text] [Related]

  • 11. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
    Yang XC, Wang X, Luo L, Dong DH, Yu QC, Wang XS, Zhao K.
    Eur Rev Med Pharmacol Sci; 2013 Jun 28; 17(12):1669-80. PubMed ID: 23832737
    [Abstract] [Full Text] [Related]

  • 12. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.
    Shi Y, Parhar RS, Zou M, Baitei E, Kessie G, Farid NR, Alzahrani A, Al-Mohanna FA.
    Hum Gene Ther; 2003 Dec 10; 14(18):1741-51. PubMed ID: 14670125
    [Abstract] [Full Text] [Related]

  • 13. RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells.
    Tabata T, Tsukamoto N, Fooladi AA, Yamanaka S, Furukawa T, Ishida M, Sato D, Gu Z, Nagase H, Egawa S, Sunamura M, Horii A.
    Biochem Biophys Res Commun; 2009 Dec 18; 390(3):475-80. PubMed ID: 19799859
    [Abstract] [Full Text] [Related]

  • 14. S100A4 mRNA as a prognostic marker and therapeutic target in Wilms tumor (WT).
    Li HJ, Chen YX, Wang Q, Zhang YG.
    Eur Rev Med Pharmacol Sci; 2014 Dec 18; 18(6):817-27. PubMed ID: 24706305
    [Abstract] [Full Text] [Related]

  • 15. Restoration of S100A4 expression enhances invasive and metastatic potentials of COLO16 cutaneous squamous cancer cells.
    Yu LJ, Li Y, Li C, Li H, Wu ML, Liu ZL, Kong QY, Chen XY, Liu XY, An LJ, Liu J.
    Cancer Biomark; 2014 Dec 18; 14(5):325-33. PubMed ID: 25171474
    [Abstract] [Full Text] [Related]

  • 16. Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation.
    Dahlmann M, Sack U, Herrmann P, Lemm M, Fichtner I, Schlag PM, Stein U.
    Oncotarget; 2012 Aug 18; 3(8):783-97. PubMed ID: 22878175
    [Abstract] [Full Text] [Related]

  • 17. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
    Liu Y, Men C, Xu Y, Zhao K, Luo L, Dong D, Yu Q.
    Cancer Biomark; 2018 Aug 18; 21(4):915-923. PubMed ID: 29400663
    [Abstract] [Full Text] [Related]

  • 18. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.
    Grum-Schwensen B, Klingelhöfer J, Beck M, Bonefeld CM, Hamerlik P, Guldberg P, Grigorian M, Lukanidin E, Ambartsumian N.
    BMC Cancer; 2015 Feb 12; 15():44. PubMed ID: 25884510
    [Abstract] [Full Text] [Related]

  • 19. Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion.
    Kim TH, Kim HI, Soung YH, Shaw LA, Chung J.
    Mol Cancer Res; 2009 Oct 12; 7(10):1605-12. PubMed ID: 19808905
    [Abstract] [Full Text] [Related]

  • 20. Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.
    Cadamuro M, Spagnuolo G, Sambado L, Indraccolo S, Nardo G, Rosato A, Brivio S, Caslini C, Stecca T, Massani M, Bassi N, Novelli E, Spirli C, Fabris L, Strazzabosco M.
    Cancer Res; 2016 Aug 15; 76(16):4775-84. PubMed ID: 27328733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.